BRIEF-Baxter shares down after drug fails in late-stage trial

NEW YORK Tue May 7, 2013 8:10am EDT

NEW YORK May 7 (Reuters) - Baxter International Inc : * Shares down 2.6 percent in premarket trade after alzeheimer's drug fail

late-stage trial

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.